Notable companies
The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY), Boston Scientific Corp (NYSE:BSX).
Industry description
The investment seeks to maximize total return.
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Market Cap
The average market capitalization across the iShares Health Innovation Active ETF ETF is 34.09B. The market cap for tickers in the group ranges from 99.03M to 380.22B. JNJ holds the highest valuation in this group at 380.22B. The lowest valued company is TCRX at 99.03M.
High and low price notable news
The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was 2%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was -7%. ORIC experienced the highest price growth at 45%, while NVCR experienced the biggest fall at -11%.
Volume
The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was 47%. For the same stocks of the ETF, the average monthly volume growth was 8% and the average quarterly volume growth was 55%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 57
P/E Growth Rating: 100
Price Growth Rating: 64
SMR Rating: 100
Profit Risk Rating: 79
Seasonality Score: 27 (-100 ... +100)